Suven Life Sciences (NSE:SUVEN) EV-to-FCF: (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUVEN Suven Life Sciences Ltd NSE:SUVEN
47 GF Score
Price ₹307.10
GF Value ₹97.45
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Suven Life Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Suven Life Sciences's Enterprise Value is ₹84,826.59 Mil. Suven Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.00 Mil. Therefore, Suven Life Sciences's EV-to-FCF for today is .

The historical rank and industry rank for Suven Life Sciences's EV-to-FCF or its related term are showing as below:

NSE:SUVEN' s EV-to-FCF Range Over the Past 10 Years
Min: -27.68   Med: 0   Max: 0
Current: -27.68

NSE:SUVEN's EV-to-FCF is ranked worse than
100% of 571 companies
in the Drug Manufacturers industry
Industry Median: 20.66 vs NSE:SUVEN: -27.68

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-03), Suven Life Sciences's stock price is ₹307.10. Suven Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-12.410. Therefore, Suven Life Sciences's PE Ratio (TTM) for today is At Loss.


Suven Life Sciences  (NSE:SUVEN) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Suven Life Sciences's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=307.10/-12.410
=At Loss

Suven Life Sciences's share price for today is ₹307.10.
Suven Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-12.410.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Suven Life Sciences EV-to-FCF Related Terms


Suven Life Sciences EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Suven Life Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suven Life Sciences EV-to-FCF Chart

Suven Life Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.83 -8.20 -25.22 -12.73 -10.87

Suven Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.73 0.00 0.00 0.00 -10.87

NSE:SUVEN vs ZTS: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Suven Life Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suven Life Sciences EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suven Life Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Suven Life Sciences's EV-to-FCF falls into.


NSE:SUVEN
47GF Score
Suven Life Sciences Ltd NSE:SUVEN
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suven Life Sciences EV-to-FCF Calculation

Suven Life Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=84826.586/0
=

Suven Life Sciences's current Enterprise Value is ₹84,826.59 Mil.
Suven Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Suven Life Sciences (NSE:SUVEN) Overvalued in 2026?

Based on GuruFocus' analysis, Suven Life Sciences stock appears to be overvalued. The current stock price of ₹307.10 is trading 215.1% above its estimated GF Value™ of ₹97.45. GuruFocus considers Suven Life Sciences to be Significantly Overvalued.

Key valuation signals for NSE:SUVEN:

  • EV-to-FCF:
  • GF Value™: ₹97.45 vs. price of ₹307.10 (215.1% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the NSE:SUVEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Suven Life Sciences Business Description

Other Exchanges 530239:India
Address Avenue 7, Road No. 5, Banjara Hills, Number 8-2-334, 6th Floor, SDE Serene Chambers, Hyderabad, TG, IND, 500 034
Suven Life Sciences Ltd is an India-based biopharmaceutical company. The company is focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. The company's only segment is providing Research and Development services. The company's geographical segment includes India; the USA; Europe and Others. The company generates maximum revenue from the USA. The company earns revenue from the sale of New Chemical Entity (NCE) based Intermediates for CNS disorders.
47GF Score

Get the complete analysis for NSE:SUVEN

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹307.10
Price
₹97.45
GF Value